John Schilling

Partner at TPG Capital

John Schilling is a prominent figure in the private equity sector, currently serving as a Partner at TPG Capital, a role he has held since 2011. In this capacity, he leads the operations team and co-leads TPG Capital's healthcare investing practice, focusing on strategic investments in the healthcare sector.1 4 5

Professional Background

Previous Roles: Before joining TPG, Schilling worked as:
- Director at Asklepios BioPharmaceutical, Inc.
- Vice President of Pharmaceutical Products Sales & Marketing at Abbott Laboratories.
- Partner at McKinsey & Co., Inc..1 2
Board Memberships: He holds various board positions, including:
- Chairman at Ellodi Pharmaceuticals.
- Director at Exactech, Inc., Beaver-Visitec International, Inc., Adare Pharma Solutions, Inc., Osteon Holdings, Inc., and BVI Holdings Ltd..1 4

Education

John Schilling completed his undergraduate studies at Duke University and earned graduate degrees from The Johns Hopkins University and The University of Chicago.1 2

Industry Impact

Schilling is recognized for his insights into the healthcare landscape, emphasizing the importance of placing physicians at the center of decision-making processes within healthcare investments.3 5 His extensive experience and leadership roles position him as a significant contributor to TPG Capital's strategic direction in healthcare and operations.

Experience

Partner at TPG Capital (2011 - Present)

Corporate Vice President, Sales and Marketing at Abbott Laboratories (2008 - 2011); Principal at McKinsey & Company (2001 - 2008)

Education

B.S. in Biomedical/Medical Engineering from Duke University; M.S. in Biomedical/Medical Engineering from The Johns Hopkins University; M.D. in Medicine from The University of Chicago; Surgical Resident and Post-Doctoral Fellow in General Surgery Residency Program at The Johns Hopkins University School of Medicine